Alfonso Valencia |
Structural Biology and Biocomputing, Spanish National Cancer Research Centre (CNIO), Madrid, Spain Epigenomics, Cancer and Evolution![]() The main interest of our Group lies in the mechanistic understanding of cancer progression by combining molecular and evolutionary approaches. Our research focuses on the problem of functional specificity and selective molecular interactions in the context of cancer genome research. The strategic goals of the Structural Computational Biology Group are: i) to analyse the function, structure and specific interactions of proteins related to cancer; ii) to develop novel methods and software platforms for the extraction, integration and representation of cancer genomic data, including the statistical analysis of molecular, genomic, epigenomic and phenotypic information in collaboration with cancer genome projects; and iii), to design the next generation of computational methods for the interpretation of personalised cancer genome information. Lab members working in projects related in Epigenomics and/or Systems Biology: Epigenomics, Genome Evolution and Networks
ICGC and Blueprint Data Managing
Alternative Splicing and Trans-splicing
|
Residing in the physical heart of the cell, the nucleus has now fully shed its once one-dimensional reputation as the repository for genetic information and steady supplier of messages to the cytoplasm. This sea change…
An open call for bilateral Franco-German projects in human epigenomics from the ANR-France has been announced! The deadline to submit a "declaration of intention" is March 29th, 2013. Click here for the announcement (in French).
Edith Heard, named a Chair of the Collège de France in Epigenetics and Cellular Memory will be giving weekly lectures starting in February that, in the tradition of this great institution, are free for anyone to attend. Lectures (in French) are from 16-17:30…
Watch the Nobel Prize winner, Sir John Gurdon, speak about winning the prize and about his revolutionary work on nuclear reprogramming.